Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects

The endogenous opioid system is involved in the pathophysiology of alcohol-use disorders. Genetic variants of the opioid system alter neural and behavioral responses to alcohol. In particular, a single nucleotide polymorphism rs1799971 (A118G) in the mu-opioid receptor gene (OPRM1) is suggested to m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bach, Patrick (VerfasserIn) , Vollstädt-Klein, Sabine (VerfasserIn) , Sommer, Wolfgang H. (VerfasserIn) , Spanagel, Rainer (VerfasserIn) , Rietschel, Marcella (VerfasserIn) , Kiefer, Falk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2015
In: European neuropsychopharmacology
Year: 2015, Jahrgang: 25, Heft: 8, Pages: 1128-1135
ISSN:1873-7862
DOI:10.1016/j.euroneuro.2015.04.013
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.euroneuro.2015.04.013
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0924977X15001169
Volltext
Verfasserangaben:Patrick Bach, Sabine Vollstädt-Klein, Martina Kirsch, Sabine Hoffmann, Anne Jorde, Josef Frank, Katrin Charlet, Anne Beck, Andreas Heinz, Henrik Walter, Wolfgang H. Sommer, Rainer Spanagel, Marcella Rietschel, Falk Kiefer

MARC

LEADER 00000caa a2200000 c 4500
001 1584480440
003 DE-627
005 20220815065118.0
007 cr uuu---uuuuu
008 181126s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.euroneuro.2015.04.013  |2 doi 
035 |a (DE-627)1584480440 
035 |a (DE-576)514480440 
035 |a (DE-599)BSZ514480440 
035 |a (OCoLC)1341024361 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bach, Patrick  |d 1987-  |e VerfasserIn  |0 (DE-588)1129478726  |0 (DE-627)884082393  |0 (DE-576)486427145  |4 aut 
245 1 0 |a Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome  |b a functional imaging study in alcohol dependent subjects  |c Patrick Bach, Sabine Vollstädt-Klein, Martina Kirsch, Sabine Hoffmann, Anne Jorde, Josef Frank, Katrin Charlet, Anne Beck, Andreas Heinz, Henrik Walter, Wolfgang H. Sommer, Rainer Spanagel, Marcella Rietschel, Falk Kiefer 
264 1 |c August 2015 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.11.2018 
500 |a Available online 18 April 2015 
520 |a The endogenous opioid system is involved in the pathophysiology of alcohol-use disorders. Genetic variants of the opioid system alter neural and behavioral responses to alcohol. In particular, a single nucleotide polymorphism rs1799971 (A118G) in the mu-opioid receptor gene (OPRM1) is suggested to modulate alcohol-related phenotypes and neural response in the mesocorticolimbic dopaminergic system. Little is known about the clinical implications of these changes. The current study investigated the relationship of genotype effects on subjective and neural responses to alcohol cues and relapse in a sample of abstinent alcohol-dependent patients. Functional magnetic resonance imaging (fMRI) was used to investigate alcohol cue-reactivity and drinking outcome of 81 abstinent alcohol-dependent patients. G-allele carriers displayed increased fMRI cue-reactivity in the left dorsal striatum and bilateral insulae. Neural responses to alcohol cues in these brain regions correlated positively with subjective craving for alcohol and positive expectations of alcohol׳s effects. Moreover, alcohol cue-reactivity in the left dorsal striatum predicted time to first severe relapse. Current results show that alcohol-dependent G-allele carriers׳ increased cue-reactivity is associated with an increased relapse risk. This suggests that genotype effects on cue-reactivity might link the OPRM1 A118G risk allele with an increased relapse risk that was reported in earlier studies. From a clinical perspective, risk-allele carriers might benefit from treatments, such as neuro-feedback or extinction-based therapy that are suggested to reduce mesolimbic reactivity. 
650 4 |a Alcoholism 
650 4 |a Endogenous opioids 
650 4 |a fMRI 
650 4 |a Relapse 
650 4 |a Single nucleotide polymorphism 
700 1 |a Vollstädt-Klein, Sabine  |d 1973-  |e VerfasserIn  |0 (DE-588)128572744  |0 (DE-627)376206330  |0 (DE-576)188335935  |4 aut 
700 1 |a Sommer, Wolfgang H.  |e VerfasserIn  |0 (DE-588)1025859626  |0 (DE-627)725315350  |0 (DE-576)370844076  |4 aut 
700 1 |a Spanagel, Rainer  |d 1961-  |e VerfasserIn  |0 (DE-588)112706312  |0 (DE-627)521941261  |0 (DE-576)289740002  |4 aut 
700 1 |a Rietschel, Marcella  |d 1957-  |e VerfasserIn  |0 (DE-588)112785751  |0 (DE-627)505574020  |0 (DE-576)289742307  |4 aut 
700 1 |a Kiefer, Falk  |d 1969-  |e VerfasserIn  |0 (DE-588)140919635  |0 (DE-627)703829033  |0 (DE-576)176310339  |4 aut 
773 0 8 |i Enthalten in  |t European neuropsychopharmacology  |d Amsterdam : Elsevier, 1990  |g 25(2015), 8, Seite 1128-1135  |h Online-Ressource  |w (DE-627)320594025  |w (DE-600)2019305-1  |w (DE-576)266224334  |x 1873-7862  |7 nnas  |a Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome a functional imaging study in alcohol dependent subjects 
773 1 8 |g volume:25  |g year:2015  |g number:8  |g pages:1128-1135  |g extent:8  |a Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome a functional imaging study in alcohol dependent subjects 
856 4 0 |u http://dx.doi.org/10.1016/j.euroneuro.2015.04.013  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0924977X15001169  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181126 
993 |a Article 
994 |a 2015 
998 |g 140919635  |a Kiefer, Falk  |m 140919635:Kiefer, Falk  |d 60000  |e 60000PK140919635  |k 0/60000/  |p 14  |y j 
998 |g 112785751  |a Rietschel, Marcella  |m 112785751:Rietschel, Marcella  |d 60000  |e 60000PR112785751  |k 0/60000/  |p 13 
998 |g 112706312  |a Spanagel, Rainer  |m 112706312:Spanagel, Rainer  |d 60000  |e 60000PS112706312  |k 0/60000/  |p 12 
998 |g 1025859626  |a Sommer, Wolfgang H.  |m 1025859626:Sommer, Wolfgang H.  |d 60000  |e 60000PS1025859626  |k 0/60000/  |p 11 
998 |g 128572744  |a Vollstädt-Klein, Sabine  |m 128572744:Vollstädt-Klein, Sabine  |d 60000  |e 60000PV128572744  |k 0/60000/  |p 2 
998 |g 1129478726  |a Bach, Patrick  |m 1129478726:Bach, Patrick  |d 60000  |e 60000PB1129478726  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1584480440  |e 3034136714 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Patrick Bach, Sabine Vollstädt-Klein, Martina Kirsch, Sabine Hoffmann, Anne Jorde, Josef Frank, Katrin Charlet, Anne Beck, Andreas Heinz, Henrik Walter, Wolfgang H. Sommer, Rainer Spanagel, Marcella Rietschel, Falk Kiefer"]},"id":{"eki":["1584480440"],"doi":["10.1016/j.euroneuro.2015.04.013"]},"person":[{"display":"Bach, Patrick","family":"Bach","role":"aut","given":"Patrick"},{"display":"Vollstädt-Klein, Sabine","role":"aut","given":"Sabine","family":"Vollstädt-Klein"},{"display":"Sommer, Wolfgang H.","given":"Wolfgang H.","role":"aut","family":"Sommer"},{"given":"Rainer","role":"aut","family":"Spanagel","display":"Spanagel, Rainer"},{"family":"Rietschel","given":"Marcella","role":"aut","display":"Rietschel, Marcella"},{"display":"Kiefer, Falk","family":"Kiefer","role":"aut","given":"Falk"}],"relHost":[{"pubHistory":["1.1990/91 -"],"titleAlt":[{"title":"ENP"}],"id":{"eki":["320594025"],"issn":["1873-7862"],"zdb":["2019305-1"]},"part":{"pages":"1128-1135","extent":"8","text":"25(2015), 8, Seite 1128-1135","issue":"8","year":"2015","volume":"25"},"origin":[{"publisher":"Elsevier","dateIssuedKey":"1990","publisherPlace":"Amsterdam","dateIssuedDisp":"1990-"}],"title":[{"subtitle":"ENP ; the journal of the European College of Neuropsychopharmacology","title_sort":"European neuropsychopharmacology","title":"European neuropsychopharmacology"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 31.01.20"],"recId":"320594025","physDesc":[{"extent":"Online-Ressource"}],"disp":"Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome a functional imaging study in alcohol dependent subjectsEuropean neuropsychopharmacology"}],"origin":[{"dateIssuedDisp":"August 2015","dateIssuedKey":"2015"}],"note":["Gesehen am 26.11.2018","Available online 18 April 2015"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"a functional imaging study in alcohol dependent subjects","title":"Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome","title_sort":"Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome"}],"physDesc":[{"extent":"8 S."}],"recId":"1584480440"} 
SRT |a BACHPATRICINCREASEDM2015